Skip to main content
Commentary
Challenges for decision-makers when assessing within-class comparative effectiveness: the case of anticoagulation therapy for atrial fibrillation
- Andrew Briggs,
- Amanda Howarth,
- Shawn Davies,
- John Schneider,
- Georgios Spentzouris,
- Farhan Mughal,
- Ahmet Fuat, and
- Matthew Fay
pp131–138
Published Online:24 January 2022
- This article corrects the following:
Corrigendum
- Volume 11Issue 7Journal of Comparative Effectiveness Research
- 3 March 2022
Research Article
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
- Craig M McDonald,
- Francesco Muntoni,
- Vinay Penematsa,
- Joel Jiang,
- Allan Kristensen,
- Francesco Bibbiani,
- Elizabeth Goodwin,
- Heather Gordish-Dressman,
- Lauren Morgenroth,
- Christian Werner,
- James Li,
- Richard Able,
- Panayiota Trifillis,
- Már Tulinius,
- M Ryan,
- K Jones,
- N Goemans,
- C Campbell,
- JK Mah,
- K Selby,
- B Chabrol,
- Y Pereon,
- T Voit,
- T Gidaro,
- U Schara,
- JB Kirschner,
- Y Nevo,
- GP Comi,
- E Bertini,
- E Mercuri,
- J Colomer,
- A Nascimento,
- JJ Vilchez,
- M Tulinius,
- T Sejersen,
- F Muntoni,
- K Bushby, and
- M Guglieri
pp139–155
Published Online:18 November 2021
Variant analysis of SARS-CoV-2 strains with phylogenetic analysis and the Coronavirus Antiviral and Resistance Database
- Murat Sayan,
- Ayse Arikan, and
- Murat Isbilen
pp157–167
Published Online:11 January 2022
Discharges against medical advice and 30-day healthcare costs: an analysis of commercially insured adults
- Eberechukwu Onukwugha,
- Aakash Bipin Gandhi, and
- David Alfandre
pp169–177
Published Online:16 November 2021
Factors impacting self-management ability in patients with chronic diseases in the United Arab Emirates, 2019
- Joel Ladner,
- Sawsan Alshurafa,
- Farah Madi,
- Anas Nofal,
- Roshel Jayasundera,
- Joseph Saba, and
- Etienne Audureau
pp179–192
Published Online:22 November 2021
Cost–effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma
- Tanja Podkonjak,
- Holly Cranmer,
- Julia Scarisbrick,
- Grant McCarthy,
- Cameron Lilley, and
- Lung-I Cheng
pp193–202
Published Online:9 December 2021
Meta-Analysis
Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis
- Chunhui Jin,
- Xiaodan Zhu,
- Xiaona Huang,
- Tingjie Gong,
- Zhipeng Wei, and
- Jianliang You
pp203–212
Published Online:13 January 2022